Patents by Inventor Christopher Barbieri

Christopher Barbieri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recurrent SPOP mutations in prostate cancer
    Patent number: 10443102
    Abstract: The invention relates generally to new prostate cancer markers, and particularly to a class of cancer marked by the presence of missense mutations in SPOP, an E3 ubiquitin ligase component. The invention provides methods and materials for detecting and diagnosing prostate cancer by detecting these mutations and may be useful in predicting disease progression and response to therapy.
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: October 15, 2019
    Assignee: Cornell University
    Inventors: Mark A. Rubin, Christopher Barbieri
  • RECURRENT SPOP MUTATIONS IN PROSTATE CANCER
    Publication number: 20130331279
    Abstract: The invention relates generally to new prostate cancer markers, and particularly to a class of cancer marked by the presence of missense mutations in SPOP, an E3 ubiquitin ligase component. The invention provides methods and materials for detecting and diagnosing prostate cancer by detecting these mutations and may be useful in predicting disease progression and response to therapy.
    Type: Application
    Filed: February 9, 2012
    Publication date: December 12, 2013
    Applicant: CORNELL UNIVERSITY
    Inventors: Mark A. Rubin, Christopher Barbieri